Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Community pharmacy

Research into community pharmacists' role in treating breast cancer funded

Pharmacy Research UK has awarded grants for research projects on topics ranging from deprescribing in hospital to the targeting of inhaled corticosteroids in chronic obstructive pulmonary disease.

How community pharmacists could play a greater role in treating breast cancer is one of five research projects awarded funding by Pharmacy Research UK (PRUK).

Almost £85,000 has been given to support pharmacy research by PRUK this year. Research training bursaries are designed to support pharmacists early in their career to develop skills and conduct research relating to their practice.

Personal research fellowships are intended to develop pharmacy practice research capacity.

Lydia Tutt, from the University of Nottingham, was awarded a training bursary of more than £10,000 for her research into the role of the community pharmacist in breast cancer services, and Victoria Tavares, from the University of Manchester, received a training bursary of £9,000 for her masters in clinical research.

Research fellowship recipients

Research fellowship awards were given to: Kimberley Sonnex of the University of Nottingham, for her work on better targeting of inhaled corticosteroids in chronic obstructive pulmonary disease; Sion Scott, from the University of East Anglia, for his research into developing a model for deprescribing in hospital; and Yeyenta Osasu, of the University of Sheffield, was given the biggest award, of almost £30,000, for her research into the prescribing, consumption and monitoring of direct oral anticoagulants in elderly patients with atrial fibrillation.

Rachel Joynes, executive director at PRUK, said she was “thrilled with the breadth, depth and quality of applications”.

“We look forward to seeing the outcomes of these projects and the valuable impact that they will have on medicines optimisation and patient care,” she said.

Applications for the 2018 round of funding awards and bursaries will open in early January 2018 and close on 2 May 2018.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203990

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • mammogram breast cancer 16

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.